SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Zuora, Inc. (ZUO) , forward earnings yield 5.79%. PEG 0.72 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (75/100, Pass) — PEG ≤ 1.0 — Peter Lynch undervalued (0.72); analyst target implies upside (+22.3%).
- Forward P/E 17.3
- PEG Ratio 0.72 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Analyst consensus target $12.25 (+22.3% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 40/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
75/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — ZUO
Valuation Multiples
P/E (TTM)0.0
Forward P/E17.3
PEG Ratio0.72
Forward PEG0.72
P/B Ratio0.00
P/S Ratio3.25
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.49
Forward EPS (Est.)$0.58
Book Value / Share$0.00
Revenue / Share$3.08
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Forward Earnings Yield5.79%
Dividend Yield0.00%
Analyst Target$12.25 (+22.3%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$-1.09 |
$92.18M |
$-48.21M |
-52.3% |
| 2017 |
$-0.88 |
$113.01M |
$-39.1M |
-34.6% |
| 2018 |
$-0.46 |
$167.93M |
$-47.16M |
-28.1% |
| 2019 |
$-0.85 |
$235.2M |
$-77.59M |
-33% |
| 2020 |
$-0.75 |
$276.06M |
$-83.39M |
-30.2% |
| 2021 |
$-0.62 |
$305.42M |
$-73.17M |
-24% |
| 2022 |
$-0.80 |
$346.74M |
$-99.43M |
-28.7% |
| 2023 |
$-0.93 |
$396.09M |
$-121.97M |
-30.8% |
| 2024 |
$-0.49 |
$431.66M |
$-68.19M |
-15.8% |
